William E. Rote
Chief Research Officer · 3 filings · Latest: May 4, 2026
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
TVTX | William E. Rote | Chief Research Officer | May 6, 2026 | Sale | $43.95 | 2,763 | $121.4K | 115,474 | |
TVTX | William E. Rote | Chief Research Officer | May 4, 2026 | Option Exercise | $0.00 | 4,250 | — | 118,237 | |
TVTX | William E. Rote | Chief Research Officer | Apr 22, 2026 | Sale | $39.09 | 9,100 | $355.7K | 113,987 | |
TVTX | William E. Rote | Chief Research Officer | Apr 13, 2026 | Grant/Award | $0.00 | 14,000 | — | 123,087 |